Page last updated: 2024-09-04

glucagon and ptr 3173

glucagon has been researched along with ptr 3173 in 1 studies

Compound Research Comparison

Studies
(glucagon)
Trials
(glucagon)
Recent Studies (post-2010)
(glucagon)
Studies
(ptr 3173)
Trials
(ptr 3173)
Recent Studies (post-2010) (ptr 3173)
26,0391,4983,0541306

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afargan, M; Bracha, M; Gelerman, G; Gilon, C; Hoffman, A; Janson, ET; Karpov, O; Liapakis, G; Oberg, K; Rosenfeld, R; Shohat, D; Stephensky, D; Wolf, A; Ziv, O1

Other Studies

1 other study(ies) available for glucagon and ptr 3173

ArticleYear
Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.
    Endocrinology, 2001, Volume: 142, Issue:1

    Topics: Animals; Binding, Competitive; Carcinoid Tumor; Cloning, Molecular; Cyclic AMP; Glucagon; Human Growth Hormone; Humans; Insulin; Insulin Secretion; Kinetics; Male; Octreotide; Pancreatic Neoplasms; Peptide Library; Radioligand Assay; Rats; Rats, Wistar; Receptors, Somatostatin; Recombinant Proteins; Somatostatin; Tumor Cells, Cultured

2001